首页> 外文期刊>European urology >Re: Erectile Function after Prostate Brachytherapy
【24h】

Re: Erectile Function after Prostate Brachytherapy

机译:回复:前列腺近距离放射治疗后的勃起功能

获取原文
获取原文并翻译 | 示例
           

摘要

This paper reports data on 128 patients who were potent before undergoing permanent prostate bra- chytherapy for prostate cancer. Potency was defined as a score of >=13 on the International Index of Erectile Function (IIEF). The 3-yr actuarial rate of potency preservation was 50.5%. The correlation between potency status after brachytherapy and dose received by the penile bulb and crura was analyzed. On multivariate analysis, the dose to the penile bulb was not significantly correlated to the potency status after brachytherapy. However, the dose delivered to 50% of the proximal crura and the preimplant potency were significantly correlated to erectile function after brachytherapy. The authors concluded that because the proximal penis is the most significant predictor of erectile dysfunction (ED) after brachytherapy, refinements in implant techniques would minimize the radiation dose to the penis and achieve potency preservation.
机译:本文报告了128例在接受永久性前列腺癌近距离放射治疗前有效的前列腺癌患者的数据。效能定义为国际勃起功能指数(IIEF)≥13。三年效价保留的精算率为50.5%。分析了近距离放射治疗后的效能状态与阴茎鳞茎和颅骨接受的剂量之间的相关性。在多变量分析中,近距离放疗后,阴茎鳞茎的剂量与效能状态没有显着相关。然而,近距离治疗后50%的药量和植入前的效力与勃起功能显着相关。作者得出结论,由于近端阴茎是近距离放射治疗后勃起功能障碍(ED)的最重要预测指标,因此植入技术的改进将使对阴茎的辐射剂量降至最低,并保持药效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号